Skip to main content

Part of the book series: Current Clinical Neurology ((CCNEU))

Abstract

The diagnosis of cerebral palsy is a clinical one, consisting of the clinical history of the mother and infant and the pediatric and neurological examination of the infant. The diagnosis is dependent on two key findings: evidence of nonprogressive damage to the developing brain and the presence of a resulting impairment of the motor (neuromuscular) control system of the body, the latter usually accompanied by a physiological impairment and functional disability.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Sources

Amyotrophic Lateral Sclerosis

  • Donaghy M. Classification and clinical features of motor neurone diseases and motor neuropathies in adults. J Neurol 1999;246:331–333.

    Article  PubMed  CAS  Google Scholar 

  • Subcommittee on Motor Neuron Diseases of World Federation of Neurology Research Group on Neuromuscular Diseases, El Escorial “Clinical Limits of ALS” Workshop Contributors. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. J Neurol Sci 1994;124:96–107.

    Article  Google Scholar 

  • Talbot K. Motor neurone disease. Postgrad Med J 2002;78:513–519.

    Article  PubMed  CAS  Google Scholar 

Cerebral Palsy

  • Cornblath DR, Feasby TE, Hahn AF, et al. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Neurology 1991;41:617–618.

    Google Scholar 

Chronic Inflammatory Demyelinating Polyneuropathy

  • Hughes R, Bensa S, Willison H, et al. Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 2001;50:195–201.

    Article  PubMed  CAS  Google Scholar 

  • Molenaar DS, Vermeulen M, de Haan R. Diagnostic value of sural nerve biopsy in chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry 1998;64:84–89.

    Article  PubMed  CAS  Google Scholar 

  • Nevo Y, Topaloglu H. 88th ENMC International Workshop: childhood chronic inflammatory demyelinating polyneuropathy (including revised diagnostic criteria), Naarden, The Netherlands, 8–10 December 2000. Neuromuscul Dis 2002; 12:195–200.

    Article  Google Scholar 

  • Nicolas G, Maisonobe T, Le Forestier N, Leger JM, Bouche P. Proposed revised electrophysiological criteria for chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 2002;25:26–30.

    Article  PubMed  Google Scholar 

  • Notermans NC, Franssen H, Eurelings M, Van der Graaf Y, Wokke JH. Diagnostic criteria for demyelinating polyneuropathy associated with monoclonal gammopathy. Muscle Nerve 2000;23:73–79.

    Article  PubMed  CAS  Google Scholar 

  • Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Neurology 1991;41:617–618.

    PubMed  Google Scholar 

  • Sander HW, Latov N. Research criteria for defining patients with CIDP. Neurology 2003;60:S8–S15.

    PubMed  Google Scholar 

  • Saperstein DS, Katz JS, Amato AA, Barohn RJ. Clinical spectrum of chronic acquired demyelinating polyneuropathies. Muscle Nerve 2001;24:311–324.

    Article  PubMed  CAS  Google Scholar 

  • Thaisetthawatkul P, Logigian EL, Herrmann DN. Dispersion of the distal compound muscle action potential as a diagnostic criterion for chronic inflammatory demyelinating polyneuropathy. Neurology 2002;59:1526–1532.

    PubMed  Google Scholar 

  • United Cerebral Palsy Research and Educational Foundation, 2002. Avaialbe via www.ucp.org.

    Google Scholar 

  • Van den Bergh PY, Pieret F. Electrodiagnostic criteria for acute and chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 2004;29:565–574.

    Article  PubMed  Google Scholar 

Dystrophinopathies

  • Jennekens FGI, ten Kate LP, de Visser M, Wintzen AR. Diagnostic criteria for Duchenne and Becker muscular dystrophy and myotonic dystrophy. Neuromuscul Dis 1991;1:389–391.

    Article  CAS  Google Scholar 

Facioscapulohumeral Dystrophy

  • Awerbuch GI, Nigro MA, Wishnow R. Beevor’s sign and facioscapulohumeral dystrophy. Arch Neurol 1990;47:1208–1209.

    PubMed  CAS  Google Scholar 

  • Brouwer OF, Padberg GW, Ruys CJM, Brand R, de Laat JAPM, Grote JJ. Hearing loss in facioscapulohumeral muscular dystrophy. Neurology 1991;41:1878–1881.

    PubMed  CAS  Google Scholar 

  • Fitzsimons RB, Gurwin EB, Bird AC. Retinal vascular abnormalities in facioscapulohumeral muscular dystrophy: a general association with genetic and therapeutic implications. Brain 1987;110:631–648.

    Article  PubMed  Google Scholar 

  • Tawil R, McDermott MP, Mendell JR, et al. Facioscapulohumeral muscular dystrophy (FSHD); design of natural history and results of baseline testing. Neurology 1994;44:442–446.

    PubMed  CAS  Google Scholar 

  • Tawil R, Figlewicz DA, Griggs RC, Weiffenbach B. FSH Consortium Facioscapulohumeral dystrophy: a distinct regional myopathy with a novel molecular pathogenesis. Ann Neurol 1988;43:279–282.

    Article  Google Scholar 

  • van der Kooi AJ, Visser MC, Rosenberg N, et al. Extension of the clinical range of facioscapulohumeral dystrophy: report of six cases. J Neurol Neurosurg Psychiatry 2000;69:114–116.

    Article  PubMed  Google Scholar 

  • Wijmenga C, Hewitt JE, Sandkuijl LA, et al. Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy. Nature Genet 1992;2:26–30.

    Article  PubMed  CAS  Google Scholar 

Guillain-Barre Syndrome

Inclusion Body Myositis

  • Amato AA, Barohn RJ. Idiopathic inflammatory myopathies. In: Pourmand R, ed. Acquired Neuromuscular Diseases, Neurologic Clinics, vol. 15(3). Philadelphia: WB Saunders, 1977.

    Google Scholar 

  • Mendell J, Barohn R, Askanas V, et al. Inclusion body myositis and myopathies. Ann Neurol 1995;38:705–713.

    Article  PubMed  Google Scholar 

Multifocal Motor Neuropathy

  • Olney RK, Lewis RA, Putnam TD, Campellone JV. Consensus criteria for the diagnosis of multifocal motor neuropathy; Muscle Nerve 2003;27:117–121.

    Article  PubMed  Google Scholar 

Myasthenia Gravis

  • ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999;42:599–608.

    Article  Google Scholar 

  • Kaminski HJ. Myasthenia Gravis and Related Disorders. Totowa: Humana Press, 2003.

    Google Scholar 

  • Vincent A, Palace J, Hilton-Jones D. Myasthenia gravis. Lancet 2001;357:2122–2128.

    Article  PubMed  CAS  Google Scholar 

Myotonic Dystrophy

  • Jennekens FGI, ten Kate LP, de Visser M, Wintzen AR. Diagnostic criteria for Duchenne and Becker muscular dystrophy and myotonic dystrophy. Neuromuscul Dis 1991;1:389–391.

    Article  CAS  Google Scholar 

Polymyositis and Dermatomyositis

  • Amato AA, Barohn RJ. Idiopathic inflammatory myopathies. Neur Clin 1997;15:615–648.

    Article  CAS  Google Scholar 

  • Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975;292:344–347.

    Article  PubMed  CAS  Google Scholar 

  • Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975;292:403–407.

    Article  PubMed  CAS  Google Scholar 

  • Chad DA. Inflammatory myopathies. In: Katirji B, Kaminski HJ, Preston DC, Ruff RL, Shapiro BE, eds. Neuromuscular Disorders in Clinical Practice. Boston: Butterworth Heinemann, 2002.

    Google Scholar 

  • Tanimoto K, Nakano K, Kano S, et al. Classification criteria for polymyositis and dermatomyositis. J Rheumatol 1995;22:668–674.

    PubMed  CAS  Google Scholar 

  • van der Meulen MF, Bronner IM, Hoogendijk JE, et al. Polymyositis: an overdiagnosed entity. Neurology 2003;61:316–321.

    PubMed  Google Scholar 

Post-Polio Syndrome

  • Borg K. Post-polio muscle dysfunction, 29th ENMC workshop: 14–16 October 1994, Naarden, The Netherlands. Neuromuscul Dis 1996;6:75–80.

    Article  CAS  Google Scholar 

Primary Lateral Sclerosis

  • Pringle CE, Hudson AJ, Munoz DG, Kiernan JA, Brown WF, Ebers GC. Primary lateral sclerosis. Clinical features, neuropathology and diagnostic criteria. Brain 1992;115:495–520.

    Article  PubMed  Google Scholar 

Spinal Muscular Atrophy

  • Bingham PM, Shen N, Rennert H, et al. Arthrogryposis due to infantile neuronal degeneration associated with deletion of the SMNT gene. Neurology 1997;49:848–851.

    PubMed  CAS  Google Scholar 

  • Brahe C, Servidei S, Zappata S, et al. Genetic homogeneity between childhood-onset and adult-onset autosomal recessive spinal muscularatrophy. Lancet 1995;346:741–742.

    Article  PubMed  CAS  Google Scholar 

  • Devriendt K, Lammens M, Schollen E, et al. Clinical and molecular genetic features of congenital spinal muscular atrophy. Ann Neurol 1996;40:731–738.

    Article  PubMed  CAS  Google Scholar 

  • Korinthenberg R, Sauer M, Ketelsen UP, et al. Congenital axonal neuropathy caused by deletions in the spinal muscular atrophy region. Ann Neurol 1997;42:364–368.

    Article  PubMed  CAS  Google Scholar 

  • Lefebvre S, Bürglen L, Frézal J, Munnich A, Melki J. The role of the SMN gene in proximal spinal muscular atrophy. Hum Mol Genet 1998;7:1531–1536.

    Article  PubMed  CAS  Google Scholar 

  • Ogino S, Wilson RB. Spinal muscular atrophy: molecular genetics and diagnostics. Expert Rev Mol Diagn 2004;4:15–29.

    Article  PubMed  CAS  Google Scholar 

  • Prasad AN, Prasad C. The floppy infant: contribution of genetic and metabolic disorders. Brain Dev 2003;7:457–476.

    Article  Google Scholar 

  • Rietschel M, Rudnik-Schöneborn S, Zerres K. Clinical variability of autosomal dominant spinal muscular atrophy. J Neurol Sci 1992;107:65–73.

    Article  PubMed  CAS  Google Scholar 

  • Russman BS. Spinal muscular atrophies. In: Katirji B, Kaminski HJ, Preston DC, Ruff RL, Shapiro BE, eds. Neuromuscular Disorders in Clinical Practice. Boston: Butterworth Heinemann, 2002.

    Google Scholar 

  • Zerres K, Davies KE. 59th ENMC International Workshop: Spinal Muscular Atrophies: recent progress and revised diagnostic criteria 17–19 April 1998, Soestduinen, The Netherlands. Neuromuscul Dis 1999;9:272–278.

    Article  CAS  Google Scholar 

  • Zerres K, Rudnik-Schöneborn S, Forkert R, Wirth B. Genetic basis of adult-onset autosomal recessive spinal muscular atrophy. Lancet 1995;346:741–742.

    Article  Google Scholar 

  • Zerres K, Wirth B, Rudnik-Schöneborn S. Spinal muscular atrophy—clinical and genetic correlations. Neuromusc Dis 1997;7: 202–207.

    Article  PubMed  CAS  Google Scholar 

Download references

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

(2006). Neuromuscular Disorders. In: Lerner, A.J. (eds) Diagnostic Criteria in Neurology. Current Clinical Neurology. Humana Press. https://doi.org/10.1007/978-1-59745-078-2_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-078-2_12

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-482-1

  • Online ISBN: 978-1-59745-078-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics